Safety and Efficacy Study of Bimosiamose Cream to Treat Psoriasis
NCT00823693 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 107
Last updated 2009-08-21
Summary
The purpose of this study is to determine whether Bimosiamose Cream is safe and effective in the treatment of plaque type psoriasis.
Conditions
Interventions
- DRUG
-
Bimosiamose Cream
- DRUG
-
Placebo Cream
Sponsors & Collaborators
-
Revotar Biopharmaceuticals AG
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
Countries
- Germany
Study Locations
More Related Trials
-
Topical CP-690,550 For Chronic Plaque Psoriasis
NCT00678561 ·Status: COMPLETED ·Phase: PHASE2
-
A Comparison of 000-0551 Lotion Versus Vehicle Lotion in Subjects With Plaque Psoriasis (Study -305)
NCT01882647 ·Status: COMPLETED ·Phase: PHASE3
-
A One-Year Study To Evaluate The Effects And Safety Of CP-690,550 In Patients With Moderate To Severe Chronic Plaque Psoriasis
NCT01276639 ·Status: COMPLETED ·Phase: PHASE3
-
Safety, Tolerability And Efficacy Study Of Topical PF-06763809 In Subjects With Mild To Moderate Chronic Plaque Psoriasis
NCT03469336 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase 3 Study in Moderate-to-Severe Plaque Psoriasis With Piclidenoson to Study Safety and Efficacy
NCT06643260 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Safety and Efficacy Study Comparing AM001 Cream, 7.5% to Vehicle Cream in the Treatment of Plaque Psoriasis
NCT03005964 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy Study of A Novel Ointment to Treat Plaque Type Psoriasis
NCT00759161 ·Status: COMPLETED ·Phase: PHASE2
-
A First in Human Study to Evaluate Safety, Tolerability, and Pharmacology of PF-06826647 in Healthy Subjects and Subjects With Plaque Psoriasis
NCT03210961 ·Status: COMPLETED ·Phase: PHASE1
-
A One-Year Study To Evaluate The Efficacy And Safety Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
NCT01309737 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy Study of A Novel Ointment to Treat Plaque Type Psoriasis
NCT00755196 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Assess the Long-Term Safety of Tacrolimus Cream in the Treatment of Psoriasis
NCT00293917 ·Status: COMPLETED ·Phase: PHASE3
-
A Comparison of 000-0551 Lotion Versus Vehicle Lotion in Subjects With Plaque Psoriasis (Study -304)
NCT01871402 ·Status: COMPLETED ·Phase: PHASE3
-
Topical Application of BMX-010 in Subjects With Atopic Dermatitis and Plaque Psoriasis
NCT03381625 ·Status: COMPLETED ·Phase: PHASE2
-
Study Of The Mechanism Of Action Of CP-690,550 In The Skin Of Subjects With Moderate To Severe Chronic Plaque Psoriasis
NCT01710046 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Assess the Safety and Effectiveness of Tacrolimus Cream in the Treatment of Psoriasis
NCT00293930 ·Status: COMPLETED ·Phase: PHASE3
-
An Efficacy and Safety Study of LYC-30937-EC in Subjects With Moderate Chronic Plaque-type Psoriasis
NCT02872285 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Assess the Safety and Effectiveness of Tacrolimus Cream in the Treatment of Psoriasis
NCT00293891 ·Status: COMPLETED ·Phase: PHASE3
-
Topical Double-blind, Randomized, Placebo-controlled Study in Psoriasis Patients
NCT01936337 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of the Efficacy and Safety of DFD-06 Cream in the Treatment of Moderate to Severe Plaque Psoriasis
NCT02635204 ·Status: COMPLETED ·Phase: PHASE3
-
To Evaluate the Efficacy and Safety of RSS0393 Ointment in Patients With Plaque Psoriasis Phase II Study
NCT06918743 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Tofacitinib Ointment For Chronic Plaque Psoriasis
NCT01831466 ·Status: COMPLETED ·Phase: PHASE2
-
Effectiveness and Safety of 3 Dosing Regimens of CP-690,550 to Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis
NCT00678210 ·Status: COMPLETED ·Phase: PHASE2
-
CP-690-550 Ointment For Chronic Plaque Psoriasis
NCT01246583 ·Status: COMPLETED ·Phase: PHASE2
-
A 12 Day Study To Evaluate A Topical Drug To Treat Plaque Psoriasis
NCT02193815 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess the Efficacy and Safety of Alefacept in Psoriasis Patients for Whom Conventional Treatment is Ineffective or Inappropriate
NCT00673556 ·Status: COMPLETED ·Phase: PHASE3